Showing results (281-290 of 753) with videos related to

Sort By:
Pageof 76
Arteriosclerosis, Thrombosis, and Vascular Biology|July 7, 2007
Wild-type ApoA-I and the Milano variant have similar abilities to stimulate cellular lipid mobilization and effluxGinny L Weibel, Eric T Alexander, Michelle R Joshi, et al.
Circulation. Genomic and Precision Medicine|July 11, 2018
Multiplexed Targeted Resequencing Identifies Coding and Regulatory Variation Underlying Phenotypic Extremes of High-Density Lipoprotein Cholesterol in HumansSumeet A Khetarpal, Paul L Babb, Wei Zhao, et al.
Journal of Lipid Research|August 5, 2018
Directional ABCA1-mediated cholesterol efflux and apoB-lipoprotein secretion in the retinal pigment epitheliumNicholas N Lyssenko, Naqi Haider, Antonino Picataggi, et al.
Atherosclerosis|September 19, 2016
A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE IEli M Roth, Patrick M Moriarty, Jean Bergeron, et al.
Nature Cardiovascular Research|February 16, 2024
Suppression of IL-1β promotes beneficial accumulation of fibroblast-like cells in atherosclerotic plaques in clonal hematopoiesisTrevor P Fidler, Andrew Dunbar, Eunyoung Kim, et al.
American Journal of Hypertension|April 10, 2017
Inflammation and Arterial Stiffness in Chronic Kidney Disease: Findings From the CRIC StudyEliot Peyster, Jing Chen, Harold I Feldman, et al.
The Journal of Clinical Investigation|July 28, 2007
Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoXun Wang, Heidi L Collins, Mollie Ranalletta, et al.
The Journal of Pediatrics|May 25, 2012
Prediabetic obese adolescents have a more atherogenic lipoprotein profile compared with normoglycemic obese peersSheela N Magge, Divya Prasad, Dorit Koren, et al.
Journal of Neurochemistry|June 15, 2005
Regulated expression of endothelial lipase by porcine brain capillary endothelial cells constituting the blood-brain barrierAndrea Sovic, Ute Panzenboeck, Andrea Wintersperger, et al.
Cardiovascular Drugs and Therapy|September 14, 2016
Efficacy and Safety of Alirocumab in Patients with Heterozygous Familial Hypercholesterolemia and LDL-C of 160 mg/dl or HigherHenry N Ginsberg, Daniel J Rader, Frederick J Raal, et al.
Pageof 76